BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $959,417 | -22.4% | 25,429 | -6.3% | 0.22% | -17.0% |
| Q2 2023 | $1,236,210 | +12.3% | 27,134 | 0.0% | 0.26% | +8.6% |
| Q1 2023 | $1,100,540 | -24.2% | 27,134 | -4.8% | 0.24% | -26.1% |
| Q4 2022 | $1,452,572 | -5.4% | 28,499 | 0.0% | 0.33% | -11.6% |
| Q3 2022 | $1,535,000 | -17.3% | 28,499 | -1.4% | 0.37% | -12.3% |
| Q2 2022 | $1,856,000 | -16.9% | 28,899 | +0.3% | 0.42% | -6.0% |
| Q1 2022 | $2,233,000 | -10.1% | 28,799 | -0.5% | 0.45% | -5.6% |
| Q4 2021 | $2,485,000 | +5.0% | 28,949 | -1.6% | 0.48% | -3.0% |
| Q3 2021 | $2,366,000 | -1.1% | 29,419 | -1.0% | 0.49% | -0.4% |
| Q2 2021 | $2,392,000 | -5.1% | 29,710 | -0.6% | 0.50% | -9.7% |
| Q1 2021 | $2,520,000 | +0.8% | 29,880 | -4.1% | 0.55% | -1.3% |
| Q4 2020 | $2,501,000 | -0.6% | 31,165 | -0.4% | 0.56% | -8.7% |
| Q3 2020 | $2,516,000 | -7.5% | 31,285 | -0.9% | 0.61% | -12.3% |
| Q2 2020 | $2,719,000 | +5.5% | 31,574 | -0.5% | 0.69% | -6.5% |
| Q1 2020 | $2,577,000 | -3.4% | 31,739 | -0.5% | 0.74% | +13.0% |
| Q4 2019 | $2,668,000 | -4.5% | 31,899 | -0.2% | 0.66% | -13.1% |
| Q3 2019 | $2,794,000 | +6.8% | 31,949 | 0.0% | 0.76% | +5.2% |
| Q2 2019 | $2,617,000 | +0.2% | 31,949 | -0.5% | 0.72% | 0.0% |
| Q1 2019 | $2,611,000 | +22.9% | 32,114 | -0.5% | 0.72% | +13.2% |
| Q4 2018 | $2,124,000 | -15.5% | 32,274 | -1.1% | 0.63% | -4.9% |
| Q3 2018 | $2,515,000 | -0.7% | 32,628 | -4.9% | 0.67% | -3.9% |
| Q2 2018 | $2,534,000 | +13.3% | 34,315 | -0.2% | 0.69% | +12.7% |
| Q1 2018 | $2,236,000 | -0.4% | 34,385 | -1.0% | 0.62% | +2.3% |
| Q4 2017 | $2,244,000 | +2.7% | 34,725 | -0.4% | 0.60% | -2.0% |
| Q3 2017 | $2,186,000 | +3.1% | 34,850 | -0.5% | 0.61% | -0.6% |
| Q2 2017 | $2,120,000 | +16.2% | 35,025 | -0.4% | 0.62% | +14.7% |
| Q1 2017 | $1,824,000 | +17.5% | 35,175 | +0.4% | 0.54% | +13.0% |
| Q4 2016 | $1,553,000 | -6.9% | 35,030 | -0.0% | 0.48% | -7.2% |
| Q3 2016 | $1,668,000 | +14.6% | 35,040 | +3.9% | 0.51% | +11.0% |
| Q2 2016 | $1,456,000 | +4.6% | 33,730 | -0.4% | 0.46% | +4.3% |
| Q1 2016 | $1,392,000 | +6.9% | 33,880 | -0.7% | 0.44% | +3.3% |
| Q4 2015 | $1,302,000 | +17.4% | 34,135 | +1.1% | 0.43% | +14.1% |
| Q3 2015 | $1,109,000 | -53.1% | 33,755 | -0.2% | 0.38% | -51.0% |
| Q2 2015 | $2,366,000 | +1.9% | 33,835 | -0.2% | 0.77% | +5.8% |
| Q1 2015 | $2,323,000 | -7.5% | 33,905 | -1.1% | 0.73% | -8.5% |
| Q4 2014 | $2,512,000 | +2.3% | 34,283 | +0.2% | 0.80% | -2.6% |
| Q3 2014 | $2,456,000 | -4.7% | 34,218 | -0.8% | 0.82% | -6.2% |
| Q2 2014 | $2,577,000 | +2.3% | 34,493 | +0.7% | 0.87% | -0.7% |
| Q1 2014 | $2,520,000 | +2.4% | 34,253 | -3.2% | 0.88% | +0.6% |
| Q4 2013 | $2,460,000 | +0.9% | 35,383 | -4.7% | 0.87% | -4.3% |
| Q3 2013 | $2,439,000 | -5.5% | 37,133 | -0.4% | 0.91% | -8.1% |
| Q2 2013 | $2,582,000 | – | 37,283 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |